annual D&A:
$8.39B-$312.00M(-3.59%)Summary
- As of today (May 29, 2025), ABBV annual depreciation & amortization is $8.39 billion, with the most recent change of -$312.00 million (-3.59%) on December 31, 2024.
- During the last 3 years, ABBV annual D&A has fallen by -$135.00 million (-1.58%).
- ABBV annual D&A is now -3.59% below its all-time high of $8.70 billion, reached on December 31, 2023.
Performance
ABBV Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$2.04B-$63.00M(-3.00%)Summary
- As of today (May 29, 2025), ABBV quarterly depreciation & amortization is $2.04 billion, with the most recent change of -$63.00 million (-3.00%) on March 1, 2025.
- Over the past year, ABBV quarterly D&A has dropped by -$35.00 million (-1.69%).
- ABBV quarterly D&A is now -11.04% below its all-time high of $2.29 billion, reached on September 30, 2020.
Performance
ABBV quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$8.35B-$35.00M(-0.42%)Summary
- As of today (May 29, 2025), ABBV TTM depreciation & amortization is $8.35 billion, with the most recent change of -$35.00 million (-0.42%) on March 1, 2025.
- Over the past year, ABBV TTM D&A has dropped by -$294.00 million (-3.40%).
- ABBV TTM D&A is now -4.88% below its all-time high of $8.78 billion, reached on September 30, 2023.
Performance
ABBV TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ABBV Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -3.6% | -1.7% | -3.4% |
| 3 y3 years | -1.6% | -0.7% | -0.1% |
| 5 y5 years | +315.8% | +264.8% | +302.9% |
ABBV Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -3.6% | at low | -9.8% | at low | -4.9% | +1.7% |
| 5 y | 5-year | -3.6% | +315.8% | -11.0% | +264.8% | -4.9% | +302.9% |
| alltime | all time | -3.6% | +1102.3% | -11.0% | +1190.5% | -4.9% | +2555.5% |
ABBV Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $2.04B(-3.0%) | $8.35B(-0.4%) |
| Dec 2024 | $8.39B(-3.6%) | $2.10B(+1.1%) | $8.39B(+0.3%) |
| Sep 2024 | - | $2.08B(-2.4%) | $8.36B(-1.8%) |
| Jun 2024 | - | $2.13B(+2.7%) | $8.52B(-1.5%) |
| Mar 2024 | - | $2.07B(-0.1%) | $8.64B(-0.6%) |
| Dec 2023 | $8.70B(+2.7%) | $2.08B(-7.1%) | $8.70B(-0.9%) |
| Sep 2023 | - | $2.23B(-1.1%) | $8.78B(+0.3%) |
| Jun 2023 | - | $2.26B(+6.3%) | $8.75B(+2.4%) |
| Mar 2023 | - | $2.13B(-1.4%) | $8.54B(+0.9%) |
| Dec 2022 | $8.47B(-0.6%) | $2.16B(-2.2%) | $8.47B(+2.1%) |
| Sep 2022 | - | $2.21B(+7.5%) | $8.29B(+0.9%) |
| Jun 2022 | - | $2.05B(-0.0%) | $8.21B(-1.8%) |
| Mar 2022 | - | $2.05B(+3.7%) | $8.36B(-1.9%) |
| Dec 2021 | $8.52B(+31.7%) | $1.98B(-7.0%) | $8.52B(-1.0%) |
| Sep 2021 | - | $2.13B(-3.3%) | $8.61B(-1.9%) |
| Jun 2021 | - | $2.20B(-0.7%) | $8.77B(+7.9%) |
| Mar 2021 | - | $2.21B(+7.3%) | $8.13B(+25.6%) |
| Dec 2020 | $6.47B(+220.8%) | $2.06B(-9.9%) | $6.47B(+31.7%) |
| Sep 2020 | - | $2.29B(+47.4%) | $4.92B(+57.2%) |
| Jun 2020 | - | $1.55B(+178.2%) | $3.13B(+50.8%) |
| Mar 2020 | - | $559.00M(+9.8%) | $2.07B(+2.8%) |
| Dec 2019 | $2.02B(+14.3%) | $509.00M(+1.2%) | $2.02B(+3.4%) |
| Sep 2019 | - | $503.00M(+0.2%) | $1.95B(+3.6%) |
| Jun 2019 | - | $502.00M(-0.2%) | $1.88B(+3.2%) |
| Mar 2019 | - | $503.00M(+13.8%) | $1.82B(+3.3%) |
| Dec 2018 | $1.76B(+17.6%) | $442.00M(+1.6%) | $1.76B(+4.3%) |
| Sep 2018 | - | $435.00M(-1.8%) | $1.69B(+3.4%) |
| Jun 2018 | - | $443.00M(-0.4%) | $1.64B(+4.1%) |
| Mar 2018 | - | $445.00M(+20.6%) | $1.57B(+4.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | $1.50B(+26.2%) | $369.00M(-2.6%) | $1.50B(+2.8%) |
| Sep 2017 | - | $379.00M(0.0%) | $1.46B(+5.4%) |
| Jun 2017 | - | $379.00M(+1.3%) | $1.39B(+6.9%) |
| Mar 2017 | - | $374.00M(+14.0%) | $1.29B(+8.9%) |
| Dec 2016 | $1.19B(+42.2%) | $328.00M(+7.9%) | $1.19B(+6.0%) |
| Sep 2016 | - | $304.00M(+5.2%) | $1.12B(+7.4%) |
| Jun 2016 | - | $289.00M(+7.8%) | $1.04B(+10.5%) |
| Mar 2016 | - | $268.00M(+2.7%) | $946.00M(+13.2%) |
| Dec 2015 | $836.00M(+6.4%) | $261.00M(+15.0%) | $836.00M(+8.9%) |
| Sep 2015 | - | $227.00M(+19.5%) | $768.00M(+4.8%) |
| Jun 2015 | - | $190.00M(+20.3%) | $733.00M(-1.6%) |
| Mar 2015 | - | $158.00M(-18.1%) | $745.00M(-5.2%) |
| Dec 2014 | $786.00M(-12.4%) | $193.00M(+0.5%) | $786.00M(-0.9%) |
| Sep 2014 | - | $192.00M(-5.0%) | $793.00M(-5.0%) |
| Jun 2014 | - | $202.00M(+1.5%) | $835.00M(-3.9%) |
| Mar 2014 | - | $199.00M(-0.5%) | $869.00M(-3.1%) |
| Dec 2013 | $897.00M(-22.0%) | $200.00M(-14.5%) | $897.00M(-10.8%) |
| Sep 2013 | - | $234.00M(-0.8%) | $1.01B(+0.7%) |
| Jun 2013 | - | $236.00M(+4.0%) | $999.00M(-5.6%) |
| Mar 2013 | - | $227.00M(-26.5%) | $1.06B(-8.0%) |
| Dec 2012 | $1.15B(-9.6%) | $309.00M(+36.1%) | $1.15B(-1.3%) |
| Sep 2012 | - | $227.00M(-23.1%) | $1.17B(-7.0%) |
| Jun 2012 | - | $295.00M(-7.5%) | $1.25B(-1.8%) |
| Mar 2012 | - | $319.00M(-1.8%) | $1.28B(+0.4%) |
| Dec 2011 | $1.27B(+7.4%) | $324.68M(+3.0%) | $1.27B(+34.3%) |
| Sep 2011 | - | $315.23M(-0.7%) | $947.32M(+49.9%) |
| Jun 2011 | - | $317.61M(+1.0%) | $632.09M(+101.0%) |
| Mar 2011 | - | $314.48M | $314.48M |
| Dec 2010 | $1.18B(+69.8%) | - | - |
| Dec 2009 | $697.49M | - | - |
FAQ
- What is AbbVie annual depreciation & amortization?
- What is the all time high annual D&A for AbbVie?
- What is AbbVie annual D&A year-on-year change?
- What is AbbVie quarterly depreciation & amortization?
- What is the all time high quarterly D&A for AbbVie?
- What is AbbVie quarterly D&A year-on-year change?
- What is AbbVie TTM depreciation & amortization?
- What is the all time high TTM D&A for AbbVie?
- What is AbbVie TTM D&A year-on-year change?
What is AbbVie annual depreciation & amortization?
The current annual D&A of ABBV is $8.39B
What is the all time high annual D&A for AbbVie?
AbbVie all-time high annual depreciation & amortization is $8.70B
What is AbbVie annual D&A year-on-year change?
Over the past year, ABBV annual depreciation & amortization has changed by -$312.00M (-3.59%)
What is AbbVie quarterly depreciation & amortization?
The current quarterly D&A of ABBV is $2.04B
What is the all time high quarterly D&A for AbbVie?
AbbVie all-time high quarterly depreciation & amortization is $2.29B
What is AbbVie quarterly D&A year-on-year change?
Over the past year, ABBV quarterly depreciation & amortization has changed by -$35.00M (-1.69%)
What is AbbVie TTM depreciation & amortization?
The current TTM D&A of ABBV is $8.35B
What is the all time high TTM D&A for AbbVie?
AbbVie all-time high TTM depreciation & amortization is $8.78B
What is AbbVie TTM D&A year-on-year change?
Over the past year, ABBV TTM depreciation & amortization has changed by -$294.00M (-3.40%)